Trial Profile
Comparison of clinical outcomes in cirrhotic chronic hepatitis B patients treated with Entecavir or Lamivudine plus Adefovir dipivoxil for 144 weeks
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Apr 2014
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Adefovir dipivoxil; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- 01 Apr 2014 New trial record